MedPath

佛山德芮可制药有限公司

Ownership
-
Established
2008-07-04
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Entecavir Tablets

Product Name
恩替卡韦片
Approval Number
国药准字H20223002
Approval Date
Jan 7, 2022
NMPA

Entecavir Tablets

Product Name
恩替卡韦片
Approval Number
国药准字H20223001
Approval Date
Jan 7, 2022
NMPA

Olanzapine Orally Disintegrating Tablets

Product Name
奥氮平口崩片
Approval Number
国药准字H20213775
Approval Date
Oct 11, 2021
NMPA

Olanzapine Orally Disintegrating Tablets

Product Name
奥氮平口崩片
Approval Number
国药准字H20213774
Approval Date
Oct 11, 2021
NMPA

Metoprolol Succinate Sustained-release Tablets

Product Name
琥珀酸美托洛尔缓释片
Approval Number
国药准字H20213731
Approval Date
Sep 13, 2021
NMPA

Metoprolol Succinate Sustained-release Tablets

Product Name
琥珀酸美托洛尔缓释片
Approval Number
国药准字H20213730
Approval Date
Sep 13, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.